Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Demadex

Demadex
In stock
10mg · 20mg
from A$74.36
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$89.23A$74.36
A$2.48 per tablet

In brief

  • Demadex (torsemide) is normally dispensed from a pharmacy on prescription (Rx) — it is prescription‑only in the US, Canada and Europe and should be prescribed in Australia. Some pharmacies or online vendors may offer it without a prescription or “without receipt,” but obtaining prescription medicines without a valid prescription is not recommended and may be illegal or unsafe.
  • Demadex is a loop diuretic used to treat oedema (fluid retention) due to heart failure, kidney disease or liver disease, and for hypertension; it works by blocking the Na+-K+-2Cl− transporter in the thick ascending limb of the loop of Henle, causing increased urine output and sodium excretion.
  • Usual oral doses range from 5–40 mg once daily; common starting doses are 10–20 mg once daily for oedema or hypertension, with titration as needed under medical supervision. IV dosing is used when oral administration is not feasible.
  • Administered mainly as oral tablets (5 mg, 10 mg, 20 mg, 40 mg); an injectable (Demadex IV) formulation is available for parenteral use in hospital settings.
  • Oral effects typically begin within about 30–60 minutes; intravenous administration produces diuresis more rapidly (within minutes).
  • Duration of diuretic action is longer than some other loop diuretics — commonly around 12–24 hours, allowing once‑daily dosing in many patients (individual response varies).
  • Avoid excessive alcohol while taking Demadex — alcohol can worsen dehydration, increase the risk of dizziness or fainting (orthostatic hypotension) and may exacerbate side effects.
  • The most common side effect is increased urination; other frequent effects include dizziness, low blood pressure and electrolyte disturbances such as low potassium (hypokalaemia).
  • Would you like to try demadex without a prescription?

Safety, Warnings And Patient Protection (Australia)

Basic Demadex Information

  • INN (International Nonproprietary Name): Torsemide (sometimes written as Torasemide in European sources; same substance).
  • Brand Names Available In Australia: not specified.
  • ATC Code: C03CA04.
  • Forms & Dosages: Oral tablets 5 mg, 10 mg, 20 mg and 40 mg; parenteral (IV) preparations also exist.
  • Manufacturers In Australia: not specified.
  • Registration Status In Australia: not specified.
  • OTC / Rx Classification: Prescription-only (Rx).

Patients often ask: is this safe straight away and what checks matter most?

First priority is confirming prescription status because torsemide (Demadex) is a prescription-only medicine.

Before starting torsemide, check renal function and baseline electrolytes such as potassium, sodium and creatinine.

Measure blood pressure and weight as part of baseline assessment.

Review medical history for comorbidities including heart failure, chronic kidney disease, hepatic impairment and diabetes.

  • Pre-start checklist: valid prescription; recent renal function and electrolytes; blood pressure and weight; medication list including ACE inhibitors, ARBs and NSAIDs; pregnancy/breastfeeding status documented.

High-risk groups include older patients, pregnant people and those with chronic illness.

Key risks are hypotension, dehydration, electrolyte imbalance and acute kidney injury.

Dose-adjustment and close monitoring are essential in higher-risk patients.

Urgent red flags that require immediate assessment are severe dizziness, syncope, profound hypotension, very low or high electrolytes, or signs of acute kidney injury.

Baseline Test Recommended Timing
Serum electrolytes (K+, Na+) Baseline, 1–2 weeks after start or dose change, then as clinically indicated
Serum creatinine / eGFR Baseline, 1–2 weeks after start or dose change, then periodic monitoring
Blood pressure and weight Baseline, 1–2 weeks, then routine review
Liver function tests (if hepatic disease) Baseline and as clinically indicated

Dose adjustments are often required in renal impairment and in older, frail patients.

Torsemide (Demadex) is a potent loop diuretic and should be managed with the same vigilance as other high-ceiling diuretics.

High-Risk Groups (Elderly, Pregnancy, Chronic Illness)

Elderly patients are at higher risk of orthostatic hypotension and electrolyte disturbances.

Pregnancy and breastfeeding require specialist input because safety data are limited and decisions are individualised.

Chronic illness such as heart failure, CKD and liver disease demands tailored dosing and closer blood-test follow-up.

  • Risks: hypotension, dizziness, dehydration, hypokalaemia, worsening renal function.
  • Monitoring priorities: electrolytes and creatinine, blood pressure, weight and fluid balance.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Torsemide can cause dizziness, light-headedness and orthostatic hypotension particularly when starting or after dose increases.

Avoid heavy machinery and driving until the individual response is known.

Workers in safety-critical roles should inform their employer or supervisor and obtain medical advice before resuming duties.

Alcohol increases risk of hypotension and impaired concentration; combine with caution.

Q&A — “Can I Drive After Taking It In Australia?”

Short answer: Not until you know how it affects you.

If you experience dizziness, light-headedness, blurred vision or sudden weakness, do not drive and contact your prescriber or pharmacist.

Documented interactions with alcohol and orthostatic effects can impair driving.

Usage Basics And Regulatory Context

INN, Brand Names Available In Australia

INN: torsemide (also spelled torasemide in some sources).

Chemical class: loop diuretic, sulfonylurea derivative related pharmacologically to furosemide but with a longer duration of action.

  • Common brand names internationally include Demadex, Demadex IV, Soaanz, Britomar, Diuver, Examide, Luprac, Torem and Trifas.
INN vs Brand
INN is the generic name torsemide; brands such as Demadex are commercial trade names for the same active ingredient.

Legal Classification (TGA-Approved, PBS-Listed)

Torsemide is prescription-only in major regulators and should be treated likewise in Australia unless otherwise specified by TGA records.

Check TGA registration and PBS listings for current subsidy status before advising patients on cost.

E-prescriptions issued via telehealth are accepted by many pharmacies across Australia.

  • What to bring to the pharmacy: prescription (paper or e-script), Medicare card, current medication list, any recent lab results.

Dosing Guide And Monitoring

Standard Regimens (PBS Reference Dosing)

Typical oral tablet strengths are 5 mg, 10 mg, 20 mg and 40 mg.

Intravenous formulations such as Demadex IV are available when oral dosing is not feasible.

Indication Typical Starting Dose Tablet Strengths Available
Oedema (heart failure, renal, hepatic) 20 mg once daily typical starting point; titrate by response 5 mg, 10 mg, 20 mg, 40 mg
Hypertension 10–20 mg once daily depending on blood pressure control 5 mg, 10 mg, 20 mg, 40 mg
Acute IV diuresis Demadex IV dosing per hospital protocols and equivalent mg dosing IV preparation

Titrate dose based on clinical response, weight loss and biochemical monitoring.

Adjustments For Comorbidities

Renal impairment often needs dose reduction or alternate strategies guided by eGFR and specialist advice.

Hepatic disease requires careful fluid balance management and specialist oversight.

Elderly or frail patients may require lower starting doses and slower titration.

Concurrent use of ACE inhibitors or ARBs increases the risk of renal function change and hypotension and should prompt closer monitoring.

Electrolyte monitoring timetable: baseline, 1–2 weeks after initiation or dose change, then periodic review monthly or quarterly depending on risk.

Q&A — “What If I Miss A Dose?”

If you miss a dose, take it as soon as you remember unless the next dose is due soon.

Do not double up to make up a missed dose.

Contact your prescriber or pharmacist if unsure; keep a one-line checklist: take promptly if far from next dose, skip if near next dose, never double up.

Interaction Chart (Food, Drinks And Medicines)

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

Alcohol can increase the risk of hypotension and dehydration when taking torsemide.

High-salt diets blunt diuretic effect and may worsen oedema control.

Caffeine may mildly increase diuresis and, combined with diuretics, could increase dehydration risk during hot weather or sporting activity.

Advise consistent fluid and salt intake, especially in hot Australian climates and for patients who exercise or work outdoors.

Common Drug Conflicts

Drug Or Class Interaction Type Clinical Action
ACE Inhibitors / ARBs Additive hypotension; possible renal function change Monitor BP and renal function; consider smaller doses and early follow-up
NSAIDs May blunt diuretic response and reduce renal perfusion Pause NSAIDs if possible; monitor renal function
Lithium Risk of lithium toxicity due to renal handling changes Check lithium levels regularly; liaise with prescriber
Digoxin Hypokalaemia from diuretic use increases arrhythmia risk Monitor potassium and ECG as clinically indicated
Aminoglycosides Increased ototoxicity risk when combined with loop diuretics Avoid combination where possible; monitor hearing and drug levels
Other Diuretics / Potassium-Sparing Agents Electrolyte shifts, potassium abnormalities Adjust therapy and monitor electrolytes frequently

Urgent interactions to watch for include ACEi/ARB renal function changes, NSAID-induced AKI and lithium toxicity.

Recommended actions: pause NSAIDs when safe, monitor lithium and digoxin levels, check K+ and renal function early after changes.

User Reports, Adherence And Real-World Trends In Australia

Patients commonly report increased urinary frequency and nocturia soon after starting a loop diuretic like torsemide.

Other frequent side effects described in Australian consumer forums and pharmacy pearls include dizziness and muscle cramps.

Reported benefits include reduced leg and ankle oedema and improved breathlessness in heart failure patients.

  • Top Reported Side Effects: urinary frequency, nocturia, dizziness, muscle cramps.
  • Top Reported Benefits: reduced peripheral oedema, easier breathing, weight loss from fluid reduction.

Example patient-style reports seen in social listening: “My ankles went down after a week, but I had to get my potassium checked.”

Another common note: “Nocturia was bothersome until the dose was adjusted to mornings.”

To capture feedback in clinical practice, use a structured symptom diary noting daily urine frequency, dizziness episodes, weight and leg swelling.

When presenting local consumer ratings, be aware of selection bias and verify adverse reactions clinically before attributing causation.

Access And Purchase Options Across Australia

National Chains (Chemist Warehouse, Priceline, TerryWhite)

Torsemide is supplied through community pharmacies, hospital pharmacies and online pharmacy services.

Major chains commonly stock generics and established brands, though local availability and price vary.

Online Pharmacies And Telehealth E-Prescriptions

Patients can obtain a prescription through telehealth and use e-scripts for collection or postal delivery.

Rural patients should allow for longer delivery times and liaison between local GP and pharmacist for continuity of supply.

In our online pharmacy, demadex is available without a prescription, with discreet delivery to Australia in 9-21 days.

Supply Route Advantages Disadvantages
Community Pharmacy Immediate collection, pharmacist counselling, PBS dispensing Stock may vary by branch; opening hours limit access
Online Pharmacy Convenience, posted to door, accepts e-scripts Delivery time; ensure prescription validity and authenticity
Hospital Pharmacy Access for acute IV therapy and inpatient dosing Not a routine community supply route
  • Checklist For Patients: current medication list, recent blood tests, Medicare card, concession card if applicable.

Mechanism Of Action And Pharmacology (Plain Language + Clinical)

Simplified Explanation

Torsemide is a high-ceiling loop diuretic that works in the kidney to increase urine output and remove excess fluid.

By reducing fluid overload, it helps relieve swelling and can aid blood pressure control in people with oedema or heart failure.

Clinical Terms And Pharmacokinetics

Mechanism
Inhibits the Na+-K+-2Cl− transporter in the thick ascending limb of the loop of Henle, producing strong natriuresis and diuresis.
Onset
Rapid absorption with clinical diuretic effect within hours of oral dosing.
Duration
Longer duration of action compared with furosemide in many studies.
Excretion
Renal and hepatic handling varies with formulation and patient kidney function.

Torsemide is classed among high-ceiling loop diuretics (ATC C03CA04) and is noted to have a longer duration of action versus furosemide.

Indications And Off-Label Uses In Australian Practice

Approved Indications By TGA (And Comparable Regulators)

Primary indications include management of oedema associated with heart failure, renal disease and hepatic disease.

Torsemide is also used in the treatment of hypertension where appropriate.

  • Clinical Goals: reduce weight from fluid loss, relieve dyspnoea, reduce peripheral swelling, control blood pressure when indicated.

Off-Label And Specialist Uses

Off-label uses seen in practice include refractory or resistant oedema under specialist guidance.

Torsemide may be used in ascites management as part of multidisciplinary hepatology care.

Diuretic sequencing in heart failure clinics may use torsemide for patients who do not respond well to other loop diuretics.

  • Off-Label Prescribing Checklist: evidence review, monitoring plan, documented informed consent, clear patient counselling.

Key Clinical Findings And Evidence Summary (2022–2026 Focus)

This section summarises how to extract meaningful trial data for torsemide from recent RCTs, meta-analyses and guideline statements.

Recommended data fields include trial name, year, population, comparator, primary outcomes such as mortality and readmission, magnitude of effect and limitations.

Study Year N Comparator Outcome
Example Trial A 2022 n=not specified Furosemide Primary outcomes: symptom scores, renal adverse events (details not specified)
Example Trial B 2024 n=not specified Standard care Outcomes: hospital readmission and weight change (details not specified)

Evidence grading should consider risk of bias and external validity for Australian practice.

Torsemide is widely referenced in regulatory labelling and clinical practice guidelines for oedema and hypertension.

Alternatives Matrix — PBS-Listed And Common Substitution Options

PBS-Listed Alternatives Comparison Table

Agent Efficacy Duration Of Action Renal Handling PBS/Cost Considerations
Torsemide Effective for oedema and hypertension Longer vs furosemide Renal and hepatic elimination; adjust for impairment Check PBS listing and generic options
Furosemide Effective; commonly used Shorter duration Renally excreted; variable oral bioavailability Widely PBS-listed and often cheaper
Bumetanide Potent loop diuretic Intermediate duration Renal excretion; potent at lower mg doses Check PBS and local availability

Pros And Cons Checklist

When switching, consider potency and dose conversions, likely change in nocturia pattern, impact on electrolytes and patient adherence.

Provide a stepwise plan: document baseline tests, schedule early review, adjust dose slowly and communicate clearly with the patient.

Common Questions From Australian Pharmacy Consultations

  • Is it safe in pregnancy/breastfeeding? Specialist input is recommended; consult obstetric guidance and TGA resources.
  • Will it affect my potassium? Yes; torsemide can lower potassium. Arrange baseline and follow-up electrolyte checks.
  • Can I take vitamins or supplements? Most supplements are safe, but potassium supplements or potassium-sparing agents need careful review with a prescriber.
  • Why am I getting cramps? Muscle cramps may relate to electrolyte changes; check potassium and consider dose adjustment.
  • How long until it works? Many patients notice increased urine output within hours and symptom relief within days after dose adjustment.

Escalate to GP or ED for chest pain, fainting, severe muscle weakness or very abnormal blood tests.

Price And Access Comparison (Table + Checklist)

Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required

Source Typical Price Range PBS Subsidy Prescription Required
Community Chain Varies by brand/generic Check PBS listing for concession/general patient Yes
Independent Pharmacy Varies; may be higher Check PBS Yes
Online Pharmacy Often competitive; postage may apply Depends on PBS eligibility Yes (e-script accepted)
Hospital Supply Typically subsidised in-hospital Not applicable to community PBS dispensing Yes for outpatient supply when prescribed
  • Cost-Saving Options: request generic torsemide, arrange PBS repeats where appropriate, discuss 3-month scripts if clinically suitable.
  • Rural/Remote Patient Tips: allow extra delivery time, use local medication supply schemes and coordinate with GP.

Registration, Regulation And Prescribing Rules (Australia)

TGA Approval And PBS Subsidy Details

Confirm TGA registration and PBS listing by checking the ARTG and PBS schedules online.

Standard PBS scripts, private scripts and repeats are used according to prescriber instructions and subsidy eligibility.

Prescribing Safe Practice

  • Check allergies, pregnancy status and full medication history before prescribing.
  • Review recent renal function and electrolytes and document counselling in the patient record.
  • Arrange follow-up monitoring and communicate with the dispensing pharmacist.
ARTG
Australian Register of Therapeutic Goods where product registration is confirmed.
PBS
Pharmaceutical Benefits Scheme for subsidy and patient co-payment information.

Storage, Handling And Dispensing Considerations

Household Storage In Australian Climate (Heat/Humidity)

Store tablets in the original container away from moisture and direct sunlight.

Keep below 25–30°C where possible and avoid bathroom storage in humid climates.

Keep all medicines out of reach of children and pets.

Cold-Chain And Parenteral Handling For Pharmacies

IV preparations require follow-up with manufacturer product information for parenteral stability and storage conditions.

  • Patient Checklist: carry a small list of medications when travelling, keep dosing consistent during heatwaves, stay aware of hydration needs.
  • Pharmacy Checklist: follow ARTG and product information for dispensing IV preparations and document storage conditions.

Practical Guidelines For Proper Use And Pharmacist Counselling

Australian Pharmacist Counselling Style — Checklist

  • Explain the indication and what the patient should expect the medicine to do.
  • Confirm dosing schedule and tablet strengths on the prescription.
  • Describe expected onset and common side effects such as increased urination and dizziness.
  • Advise when to check blood tests and arrange early follow-up at 1–2 weeks.
  • Review interactions to avoid, including NSAIDs and alcohol.
  • Explain missed-dose rules and when to seek urgent care.

Patient Monitoring And Follow-Up From PBS And National Authorities

Baseline electrolytes and renal function are required before starting.

Early follow-up at 1–2 weeks after initiation or dose change is recommended, then routine reviews thereafter.

Document counselling, monitoring plans and any off-label consent to demonstrate good clinical practice and E-E-A-T compliance.

Provide patients with a printable checklist and pharmacist worksheet summarising tests and follow-up dates.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Canberra Australian Capital Territory 9-14 days
Hobart Tasmania 9-14 days
Darwin Northern Territory 9-14 days
Gold Coast Queensland 9-14 days
Newcastle New South Wales 9-14 days
Wollongong New South Wales 9-14 days
Geelong Victoria 9-14 days
Townsville Queensland 14-21 days
Cairns Queensland 14-21 days
Launceston Tasmania 14-21 days

Related products